Beta-Adrenergic Bronchodilators
- 1 January 1986
- journal article
- other
- Published by S. Karger AG in Respiration
- Vol. 50 (2) , 97-102
- https://doi.org/10.1159/000195107
Abstract
Long-acting beta2-selective agonists have become a major form of therapy of reversible airway obstruction. Modern agents are effective by all routes of administration and can both eliminate bronchospasm as well as prevent its occurrence. Many drugs such as albuterol, terbutaline and fenoterol have similar pharmacologic profiles, and there is frequently little to choose between them. The majority of the available data indicate that aerosol therapy produces as much bronchodilatation as the oral and parenteral routes with much fewer side effectsKeywords
This publication has 0 references indexed in Scilit: